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S U M M A R Y
Background: Contaminated textiles in hospitals contribute to endogenous, indirect-contact, and aerosol
transmission of nosocomial related pathogens. Copper oxide impregnated linens have wide-spectrum
antimicrobial, antifungal, and antiviral properties. Our aim was to determine if replacing non-biocidal
linens with biocidal copper oxide impregnated linens would reduce the rates of healthcare-associated
infections (HAI) in a long-term care ward.
Methods: We compared the rates of HAI in two analogous patient cohorts in a head injury care ward over
two 6-month parallel periods before (period A) and after (period B) replacing all the regular non-biocidal
linens and personnel uniforms with copper oxide impregnated biocidal products.
Results: During period B, in comparison to period A, there was a 24% reduction in the HAI per 1000
hospitalization-days (p < 0.05), a 47% reduction in the number of fever days (>38.5 8C) per 1000
hospitalization-days (p < 0.01), and a 32.8% reduction in total number of days of antibiotic
administration per 1000 hospitalization-days (p < 0.0001). Accordingly there was saving of
approximately 27% in costs of antibiotics, HAI-related treatments, X-rays, disposables, labor, and
laundry, expenses during period B.
Conclusions: The use of biocidal copper oxide impregnated textiles in a long-term care ward may
signiﬁcantly reduce HAI, fever, antibiotic consumption, and related treatment costs.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Copper has been used as a biocide for centuries.1 The fungicidal,
antibacterial, and antiviral properties of copper have been
demonstrated in many controlled laboratory studies and are very
well documented.2,3 Copper exerts its toxicity to microorganisms
through several parallel non-speciﬁc mechanisms, which include
damage to the microorganisms’ envelope and intracellular
proteins and nucleic acids.3 Many bacteria and fungi have different* Corresponding author. Tel.: +972 547791928.
E-mail address: lazary@reuth.org.il (A. Lazary).
http://dx.doi.org/10.1016/j.ijid.2014.01.022
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).mechanisms to deal with excess copper.2 However, above a certain
threshold and time of exposure, they cannot deal with the copper
overload and die. In contrast to the highly antibiotic-resistant
microbes that have evolved over less than 50 years, microorgan-
isms tolerant to copper are extremely rare even though copper has
been a part of the earth for millions of years. This can be explained
by the multisite and non-speciﬁc kill mechanisms of copper.2
Signiﬁcantly, copper also displays potent biocidal activity against
antibiotic-resistant bacteria and antiviral-resistant viruses.3–5
Copper and copper-based compounds are used routinely in
several health-related areas. These include the control of
Legionella6 in hospital water distribution systems, reduction of
caries in dentistry,7 reduction of food-borne diseases,8 and theciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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used by millions of women, are approved by the regulatory agencies,
and have been applied for several decades.9 It has recently been
demonstrated in hospitals, clinics, and care homes for the elderly,
that substituting the existing hard surfaces with copper-based
surfaces reduces the bioburden and the transmission of nosocomial
pathogens.10,11 The US Environmental Protection Agency (EPA)
approved the registration of copper alloys and polymeric surfaces
containing copper oxide particles as materials with antimicrobial
properties that can kill >99.9% of Gram-negative and Gram-positive
bacteria within 2 h of exposure, making copper the only metal that
can be used in hospitals to reduce the bioburden and for which
public health claims can be made.
In the last few years, a durable platform technology has been
developed that permanently embeds copper oxide particles into
polymeric materials.4 The introduction of copper oxide particles
into polymeric materials endows them with potent broad-
spectrum antimicrobial4,5,12 and anti-mite properties,4,13 and in
some applications has a direct effect on physiological processes,
such as enhanced wound healing.14 Since copper oxide is a non-
soluble form of copper, the copper oxide particles do not wash out
during laundry and the textile products remain active for the life of
the products.4,12
Consumer products impregnated with copper oxide particles,
such as pillowcases, sheets, and diapers, are extremely safe and doFigure 1. Two scanning electronic microscope images (taken with a Jeol JMS 840 scannin
the copper oxide particles embedded in the polyester ﬁbers. The chart is an X-ray photo
system) of the encircled white dot, showing a peak at 8 KeV corresponding to copper.not cause any skin irritation or sensitization, or any adverse
reactions, both to intact and breached skin.15 This has been
demonstrated (1) in animal studies;4,12,16,17 (2) in several double-
blind clinical trials;18–20 (3) with patients who slept on sheets
containing copper oxide for a total of 300 nights;12 and (4) in adult
patients using diapers containing copper oxide for a period of 6
months, without even one adverse reaction.21
The innovative potential use of this technology in health-
related applications include making hospital soft surfaces, like
sheets, patient robes, patient pajamas, nurse clothing, and diapers,
from copper oxide impregnated biocidal textiles.4,12,16,22 It was
hypothesized that the use of copper oxide containing textiles,
especially sheets, pillowcases, robes, and pajamas that are in close
contact with the patients, may signiﬁcantly reduce the bioburden
in the products themselves and in the surrounding environment
and consequently reduce the risk of HAI.22 In order to test this
hypothesis we examined if the HAI rates in a long-term care ward
could be reduced when all the textile products used in the ward
were replaced with biocidal copper oxide containing textiles
(Figure 1).
2. Materials and methods
The study was conducted in the Head Injury Ward, following
approval by the hospital institutional review board. Since allg electron microscope) of a representative pillowcase are shown. The white dots are
electron spectra analysis (done with a Shimadzu XRD 6000, TN-5500 X-ray analysis
Table 1
Surveillance deﬁnitions of HAI used in the study
Type of infection Criteria
A. Upper respiratory 1. Pharyngitis (at least two criteria outlined below)
a. Runny nose or sneezing
b. Stuffy nose (i.e., congestion)
c. Sore throat or hoarseness or difﬁculty in swallowing
d. Dry cough
e. Swollen or tender neck glands (cervical lymphadenopathy)
2. Inﬂuenza-like illness (both criteria a and b were present)
a. Fever
b. At least three of the following inﬂuenza-like illness sub-criteria
 Chills
 New headache or eye pain
 Myalgias or body aches
 Malaise or loss of appetite
 Sore throat
 New or increased dry cough
B. Lower respiratory 1. Pneumonia (all three criteria were present)
a. Positive chest radiograph demonstrating pneumonia or presence of a new inﬁltrate
b. At least one of the following respiratory sub-criteria was present
 New or increased cough
 New or increased sputum production
 O2 saturation <94% on room air or a reduction in O2 saturation of >3% from baseline
 New or changed lung examination abnormalities
 Pleuric chest pain
 Respiratory rate of 25 breaths/min
c. At least one of the following sub-criteria was present
 Fever (single oral/axillary/rectal temperature >38.5 8C)
 Leukocytosis (>14  109 leukocytes/l or >6% bands or 1.5  109 bands/l)
 Acute change in mental status from baseline
 Acute functional decline
2. Bronchitis or tracheobronchitis (all three criteria were present)
a. Chest radiograph not performed or negative results for pneumonia or new inﬁltrate
b. At least two of the respiratory sub-criteria listed in section Bb above
c. At least one of the sub-criteria listed in section Bc above
C. Urinary tract 1. No indwelling catheter (both criteria 1 and 2 were present)
a. At least one of the following signs or symptom sub-criteria
 Acute dysuria or acute pain, swelling, or tenderness of testes, epididymitis, or prostate
 Fever or leukocytosis and at least one of the following
– Acute costovertebral angle pain or tenderness
– Suprapubic pain
– Gross hematuria
– New or marked increase in incontinence
– New or marked increase in urgency
– New or marked increase in frequency
 In the absence of fever or leukocytosis, then two or more of the following sub-criteria
– Suprapubic pain
– Gross hematuria
– New or marked increase in incontinence
– New or marked increase in urgency
– New or marked increase in frequency
b. One of the following microbiological sub-criteria
 At least 105 CFU/ml of no more than two species of microorganisms in a voided urine sample
 At least 102 CFU/ml of any number of organisms in a specimen collected by in-and-out catheter
2. With indwelling catheter (both criteria 1 and 2 were present)
a. At least one of the following signs or symptom sub-criteria
 Fever, rigors, or new-onset hypotension, with no alternate site of infection
 Acute change in mental status, with no diagnosis and leukocytosis
 New onset suprapubic pain or costovertebral angle pain or tenderness
 Purulent discharge from around the catheter or acute pain, swelling or tenderness of testes, epididymitis, or prostate
b. Urinary catheter specimen culture with at least 105 CFU/ml of any microorganism
D. Skin At least 1 of the following criteria were found
a. Pus at a wound or skin site
b. New or increasing presence of at least four of the following sub-criteria
 Heat at the affected site
 Redness at the affected site
 Swelling at the affected site
 Tenderness or pain at the affected site
 Serous drainage at the affected site
 One of the sub-criteria
– Fever
– Leukocytosis
E. Eye At least one of the following
a. Pus appearing from one or both eyes, for at least 24 h
b. New or increased conjunctival erythema, with or without itching
c. New or increased conjunctival pain for at least 24 h
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Table 1 (Continued )
Type of infection Criteria
F. Mouth Both criteria were present
a. Presence of raised white patches on inﬂamed mucosa or plaques on oral mucosa
b. Diagnosis by a medical or dental provider
G. GI At least two of the following criteria were present
a. Diarrhea; 2 liquid or watery stools above the normal for the patient within a 24-h period
b. Vomiting; 2 episodes in a 24-h period
c. A stool specimen testing positive for a pathogen
H. Blood Both criteria were present
a. Recognized pathogen isolated from blood culture and pathogen was not related to infection at another site (contamination)
b. Clinical sepsis with one of the following clinical signs:
 Fever (>38.5 8C)
 Chills
 Hypotension (systolic pressure 90 mmHg)
 Oliguria (<20 cm3/h)
I. Other infections Osteomyelitis, otitis, orchitis
HAI, healthcare-associated infection; GI, gastrointestinal.
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not legally eligible, their custodians signed an informed consent
form. The Head Injury Ward is a 35-bed ward in which long-term
care patients with severe head injuries are hospitalized. All the
patients are conﬁned to bed and wheel chair. They are totally
dependent on medical personnel for everyday needs and activities.
The most common medical complication that afﬂicts these
patients is infection, which is also the main cause of death.23–25
Patients are usually hospitalized for a period of a few months to
several years. During both study periods, >90% of the patients were
immunized against seasonal inﬂuenza.
The data were gathered during two 6-month parallel periods:
period A, December 2010 to June 2011, and period B, December
2011 to June 2012. Data collected were: patient ID, age, and sex;
date of admission to the ward; date of discharge from the ward;
main diagnosis and medical background; mobility (yes, no, or
conﬁned to bed); tracheostomy (yes or no); urinary catheter (yes or
no); feeding tube (yes or no); sores (admitted to the ward with
sores, yes or no); drug treatments; antibiotic treatments (types,
period of treatment, and times of treatments); steroid treatments
(yes or no); inhalations (yes or no); fever (times of fever >38.5 8C);
and infection (date of infection, type, and duration). An infection
event and the type of infection was determined according to the
criteria deﬁned by Embry and Chinnes26 and in accordance with
the revised McGeer criteria for deﬁning an infection event of a
patient hospitalized in a long-term care facility.27 These criteria are
detailed in Table 1.
During period A, the regular non-biocidal hospital linens were
used in the ward. During period B, all bed sheets, pillowcases,
patient shirts, patient pants, patient gowns, towels, underpads, and
personnel robes used in the ward were replaced with copper oxide
impregnated products. The textile products were distinguished
from the regular hospital products by having a different color. They
were used exactly as any of the regular hospital products are used.
The used products were laundered in the same laundry, where all
hospital linens are laundered, using the exact laundry conditions as
those used with the regular hospital products. The routine
infection control measures, such as standard precautions, isolation
of patients infected with antibiotic-resistant bacteria (MDR,
multidrug-resistant), and hand hygiene were the same during
period A and period B. The standard precautions to prevent cross-
contamination were monitored in both studied periods in the same
strict and rigorous manner and by the same infection control nurse.
No other environmental or treatment modality changes occurred
in the ward during the two periods, other than the use of the
biocidal textiles. No changes were made or instituted in the ward
during the intermediary period (July–November 2011). The
hospital staff who actually took care of the patients (i.e., the warddoctors, nurses, and nurse aides) in the ward itself were not
involved directly in the trial. The only change that they saw in the
ward was the color of the linens. The ward staff were not aware of
the parameters monitored and studied. All the data gathered for
the study were collected from the patients’ medical ﬁles, from the
pharmacy reports, and from the laboratory reports, without the
knowledge or involvement of the ward medical staff.
2.1. Microbiology testing
Forty regular bed sheets and 40 copper oxide impregnated bed
sheets were swabbed between 6 to 7 h after being used by patients
in a regular ward and in the Brain Injury Ward, respectively, as
described previously.28 An area of 10 cm2 of each sheet was
swabbed in the area that was in contact with the patient’s back.
The presence of microorganisms, their titers, and characterization
were then determined by regular standard microbiology assays.
2.2. Statistical analyses
The statistical analyses were performed by MediStat Ltd, a
company that specializes in biostatistical analyses (http://
www.medistat.co.il/). The differences between the two popula-
tions studied in terms of patient medical characteristics, treat-
ments, and nosocomial infections, were compared. The Chi-square
test was applied to test the statistical signiﬁcance of the differences
in frequencies of categorical variables between periods. Weighted
Chi-square tests were applied to test the statistical signiﬁcance of
the differences in sum of variables between periods. The two-
samples t-test was applied to test the statistical signiﬁcance of the
differences in means of continuous variables between periods. The
Mann–Whitney rank sum test was used to test the difference
between the bacterial loads in the regular and copper oxide
impregnated sheets after use. The effect of possible cofounders was
analyzed by conducting multivariate analysis of covariance
(ANCOVA). All tests applied were two-tailed, and a p-value of
0.05 or less was considered statistically signiﬁcant. The data were
analyzed using SAS version 9.1 (SAS Institute, Cary, NC, USA).
3. Results
The patient groups hospitalized during the two periods
compared had similar characteristics and underwent similar
treatments not related to HAI (Tables 2 and 3). In contrast, as
can be seen in Table 4, there was a 24% reduction in HAI events that
occurred in period B as compared to period A (p = 0.046). Of note
was the signiﬁcant decrease in the number of days the patients had
fever (47%; p = 0.0085). It should be pointed out that each time a
Table 2
Patient characteristics
Variable Period A Period B
Number of patients 57 51
Total hospitalization days 4337 3940
Mean age, years 57  19 49.7  22
Age range, years 18–90 19–83
Female/male ratio 1:2 1:2.6
Table 5
HAI distribution
Infection Period A Period B % Decrease p-Value
Numbera % Numbera %
GI 13 92.86 1 7.14 92.3 0.0013
Eyes 20 68.97 9 31.03 55 0.0411
Respiratory, upper 18 40.91 26 59.09 - 0.2278
Respiratory, lower 23 57.50 17 42.50 - 0.3428
Urinary 9 64.29 5 35.71 - 0.2850
Skin 27 56.25 21 43.75 - 0.3865
Blood 2 100.00 0 0 - -
Mouth 3 100.00 0 0 - -
Other infections 3 50.00 3 50.00 - 1.0000
HAI, healthcare-associated infection.
a Number of events.
Table 3
Clinical characteristics of the study populations (%)
Variable Period A Period B p-Value
Mobile patients 10.2 13.8 0.797
Patients with tracheostomy 61.0 63.8 0.538
Patients with urinary catheter 31.3 22.2 0.449
Patients with feeding tube 72.5 69.4 0.694
Patient with pressure soresa 25.9 16.7 0.298
Patients receiving steroids 30.4 19.4 0.245
Patients receiving inhalations 49.1 41.7 0.482
a The patients were admitted to the ward with pre-existing sores. No sores
developed in the ward during the study period.
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in 98.5% of the cases the fever did not persist more than 1 day. In
accordance, there was a 23% reduction in the number of events in
which patients received antibiotics during period B as compared to
period A (p = 0.052). Moreover, the total days of antibiotic
administration during period B was 32.8% lower than in period
A (p < 0.0001). The inﬂuence of potential confounders, such as
patient age, gender, mobility, presence of sores, steroid adminis-
tration, tracheostomy, urinary catheter, and inhalation treatments,
on the differences found in fever days, use of antibiotics, and rates
of HAI, was negated by conducting ANCOVA analyses. The HAI
distribution is detailed in Table 5. Statistically signiﬁcant reduc-
tions in gastrointestinal (GI) and eye infection events (p = 0.0013
and p = 0.0411, respectively) occurred in period B as compared to
period A. No blood or mouth infections were recorded during
period B. No statistical differences were noted in the other HAI
events.
Signiﬁcantly lower loads of Gram-positive and Gram-negative
bacteria were found in the copper oxide containing sheets than in
regular sheets after 6–7 h of patient use (reductions of approxi-
mately 50% and 46%, respectively; Figure 2). The Gram-positive
bacteria found were Bacillus and Staphylococcus epidermis. The
Gram-negative bacteria found were Acinetobacter baumannii,
Enterobacter cloacae, Escherichia coli (only on one regular sheet),
Klebsiella pneumoniae, and Pseudomonas stutzeri. Candida albicans
was found on one regular sheet.
4. Discussion
It was hypothesized that the use of biocidal textiles instead of
ordinary textiles may signiﬁcantly reduce nosocomial infections inTable 4
HAI-related eventsa
Variable Period A 
Numberb % 
HAI 27.4 56.85 
Fever days 13.4 65.36 
Number of times antibiotics given 21.44 56.51 
Total days of antibiotics 382.7 59.82 
HAI, healthcare-associated infection.
a Data normalized per 1000 hospitalization days.
b Number of events.hospital wards.22 This was based on the following: microbial
shedding from the living body occurs all the time.29 When a
bacterium is shed into a textile fabric between the patient and the
bed, either the pajamas or directly onto the sheet, the moisture and
temperature in the textile microenvironment promotes its
proliferation. Bed-making releases large quantities of microorgan-
isms into the atmosphere, contaminating the immediate and
distant surroundings.30,31 For example, methicillin-resistant
Staphylococcus aureus (MRSA) was detected following bed-making
on the bed sheets, over-bed tables, and the patients’ clothing.32
Similar results were reported following undressing and redressing
of patients.33 These studies strongly support the notion that
disturbance of textiles in clinical settings may contribute to the
dispersal of pathogens into the air, which then settle down and
contaminate the immediate and non-immediate environment.
Healthcare workers can then transport these pathogens to patients
by the contact route.34
In addition to being a source of aerosol transmission of
microorganisms, contaminated textiles can also directly contami-
nate the hospital personnel. Forty-two percent of personnel who
had no direct contact with patients, but who had touched different
surfaces including bed linens, contaminated their gloves with
MRSA.35 The transmission of Streptococcus pyogenes occurred via
contact with the contaminated surface of a vinyl sheet that covered
the bed on which the patients were treated.36 Similarly, bedding
was a signiﬁcant risk factor related to a nosocomial outbreak of
Norwalk gastroenteritis.37 Also staff clothing, such as uniforms, has
been found to be highly contaminated with, for example, high
levels of MRSA.38 Hospital staff, even when using protective
equipment such as gloves, can become contaminated themselves
by touching the contaminated textiles and then transfer the
microorganisms to other patients directly or indirectly by
contaminating other surfaces, such as door knobs.35
While the notion that contaminated textiles in hospitals can be
an important source of microbes contributing to endogenous,
indirect-contact, and aerosol transmission of nosocomial related
pathogens is gaining recognition,22 the demonstration that the use
of biocidal textiles in a clinical environment can be an important
simple measure to ﬁght HAI had not been done, until this study.Period B % Decrease p-Value
Numberb %
20.8 43.15 24 0.046
7.1 34.63 47 0.0085
16.5 43.49 23 0.052
257.1 40.18 32.8 <0.0001
Figure 2. Bacterial loads found on the regular and copper oxide impregnated sheets.
Forty regular bed sheets and 40 copper oxide impregnated bed sheets were
swabbed immediately after being used by patients for 6–7 h. The swabs were taken
from the area that was in contact with the patient’s upper back.
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ward, as most of the patients hospitalized in this ward are very
fragile and susceptible to infection. Unfortunately the rate of HAI in
these patients is very high and is actually the most common
medical complication that afﬂicts them.23–25 We assumed that
with a cohort of patients suffering from a high rate of infections, it
would be appropriate to demonstrate the beneﬁcial effect of using
biocidal textiles in reducing HAI in a relatively short period of time,
and that results may be more signiﬁcant.
Indeed, this study indicates that the HAI rates in a long-term
care ward could be reduced simply by replacing the textile
products used in the ward with biocidal copper oxide containing
textiles. As expected, in the copper oxide impregnated fabrics there
were signiﬁcantly lower loads of pathogenic bacteria such as A.
baumannii and K. pneumoniae. A clear indication that there was a
reduction in infections when the copper oxide biocidal textiles
were used was the signiﬁcant reduction in the number of events in
which patients had a fever >38.5 8C. Such a fever can be a clinical
indication of an infection, sometime being the only clinical sign.
There was a reduction of approximately 50% in the number of high
fever measurements recorded in the ward during period B as
compared to the corresponding period A. There was also a clear
reduction in the total HAI rates during period B, which resulted
mainly from the signiﬁcant reduction in GI infections and
conjunctiva-associated eye infections. The reduction in GI infec-
tions can be explained by the reduction in antibiotics given to the
patients. It is well known that the use of antibiotics can induce
diarrhea and reactivate Clostridium difﬁcile in silent carriers.
Conjunctiva-associated eye infections may be associated with
airborne bacteria released during bed-making,32,33 since many of
the brain injury patients lie down with their eyes open. Thus the
reduction in airborne bacteria that results from the use of biocidal
linens reduces the risk of contracting an eye infection.It should be noted that in order to eliminate seasonal variations
between the examined periods, the two periods compared were
similar, i.e. period A was from December 2010 to June 2011, and
period B was from December 2011 to June 2012. There were no
statistical differences in the rates of HAI that are often associated
with insertion or manipulation of selective biomedical devices,
such as urinary catheters, central lines, and respiratory equipment,
between the two periods. This can be explained by the fact that
most of these infections are caused by the handling of the
inhalation tubes by staff and due to constant contamination of the
inhalation tubes by the patient’s oral secretions, which do not
come into contact with the biocidal linens, and thus are not
affected by them, and apparently are less related to airborne
bacteria. The population studied is not ventilated, thus there is no
ventilator-associated pneumonia. The patients with indwelling
urinary catheters were identical in the two studied populations.
There were no central lines in those patients.
This study demonstrated that the use of copper oxide
containing linens reduced HAI in a long-term care ward. There
is no reason to believe that reducing the bioburden in a regular
ward by using biocidal linens would not affect the HAI rates. The
use of biocidal textiles should be a complementary approach to
ﬁght nosocomial infections in all medical institutions, as well as
care homes for the elderly, where the risks of acquiring an infection
are high. Importantly, the biocidal efﬁcacy of the copper oxide has
been demonstrated not to be affected even after 100 commercial
laundry cycles and years of use.12,20
Obviously longer trials, including trials comparing HAI during
consecutive 12-month periods rather than parallel 6-month ones,
or trials in which two similar wards are supplied with either the
copper oxide impregnated linens or non-treated matched linens,
without the personnel knowing what the meaning of the colors are,
would be better experimental designs and should be used in future
studies.
The use of copper oxide containing linens also results in
signiﬁcant cost savings. As calculated by the hospital, there was a
dramatic reduction in the costs in treating patients during period B
as compared to the parallel period A. The reduction was in the costs
of antibiotics, HAI-related treatments, X-rays, disposables, labor,
laundry, etc., which averaged a saving of approximately 27% (data
not shown). It should be pointed out that in this long-term care
ward, patients are hospitalized for many months to years, so if they
have an HAI it does not usually result in a prolonged hospitaliza-
tion as is the case in non-chronic care wards. Most cases of HAI
result in prolonged hospitalization and an associated signiﬁcant
increase in the costs, both to the hospital and to the insurance
companies. These costs were not taken into consideration in the
current study.
The results of this study clearly demonstrate that the use of
copper oxide impregnated linens in a long-term care ward reduce
HAI and antibiotic and other infection-related treatments, and can
be an important addition to the arsenal of measures taken in
hospitals to reduce an important source of nosocomial pathogens
and the risk of HAI. Due to the good results obtained in reducing
infections, the hospital where this study was carried out is in the
process of replacing the linens and staff protective clothing
throughout the hospital.
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